HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Colon cancer after infliximab therapy for Crohn's disease in a young patient transplanted for primary sclerosing cholangitis.

AuthorsLaurent Peyrin-Biroulet, Aude Bressenot, Laurence Chone, Philippe Denjean, Patrick Boissel, Marc-André Bigard, Jean-Pierre Bronowicki
JournalThe American journal of gastroenterology (Am J Gastroenterol) Vol. 101 Issue 11 Pg. 2664-5 (Nov 2006) ISSN: 0002-9270 [Print] United States
PMID17090288 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Infliximab
Topics
  • Adenocarcinoma (chemically induced)
  • Adult
  • Antibodies, Monoclonal (adverse effects)
  • Cecal Neoplasms (chemically induced)
  • Cholangitis, Sclerosing (surgery)
  • Colonic Neoplasms (chemically induced)
  • Crohn Disease (drug therapy)
  • Gastrointestinal Agents (adverse effects)
  • Humans
  • Infliximab
  • Liver Transplantation
  • Male
  • Postoperative Complications

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: